| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 215,394 | 230,875 | 288,721 | 264,104 | | Cost of Revenue | 122,166 | 121,346 | 164,465 | 129,519 | | | Gross Profit | 93,228 | 109,529 | 124,256 | 134,585 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 75,809 | 73,345 | 80,624 | 84,377 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,419 | 36,184 | 43,632 | 50,208 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 202 | 307 | 690 | 151 | | Earnings Before Interest And Taxes | 17,621 | 36,491 | 44,322 | 50,359 | | Interest Expense |
-
|
-
| 208 |
-
| | Income Before Tax | 17,621 | 36,491 | 44,114 | 50,359 | | Income Tax Expense | 5,459 | 14,684 | 14,630 | 19,412 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,162 | 21,807 | 29,484 | 30,947 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,162 | 21,807 | 29,484 | 30,947 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,162 | $21,807 | $29,484 | $30,947 |
|
0.55% Nasdaq 
Income Statement
